» Articles » PMID: 17982457

A Survey of Genetic Human Cortical Gene Expression

Abstract

It is widely assumed that genetic differences in gene expression underpin much of the difference among individuals and many of the quantitative traits of interest to geneticists. Despite this, there has been little work on genetic variability in human gene expression and almost none in the human brain, because tools for assessing this genetic variability have not been available. Now, with whole-genome SNP genotyping arrays and whole-transcriptome expression arrays, such experiments have become feasible. We have carried out whole-genome genotyping and expression analysis on a series of 193 neuropathologically normal human brain samples using the Affymetrix GeneChip Human Mapping 500K Array Set and Illumina HumanRefseq-8 Expression BeadChip platforms. Here we present data showing that 58% of the transcriptome is cortically expressed in at least 5% of our samples and that of these cortically expressed transcripts, 21% have expression profiles that correlate with their genotype. These genetic-expression effects should be useful in determining the underlying biology of associations with common diseases of the human brain and in guiding the analysis of the genomic regions involved in the control of normal gene expression.

Citing Articles

Transcription Factor-Wide Association Studies to Identify Functional SNPs in Alzheimer's Disease.

Dunn J, Moore C, Kim N, Gao T, Cheng Z, Jin P J Neurosci. 2024; 45(2.

PMID: 39622643 PMC: 11714347. DOI: 10.1523/JNEUROSCI.1800-24.2024.


Chromosome X-wide association study in case control studies of pathologically confirmed Alzheimer's disease in a European population.

Simmonds E, Leonenko G, Yaman U, Bellou E, Myers A, Morgan K Transl Psychiatry. 2024; 14(1):358.

PMID: 39231932 PMC: 11375158. DOI: 10.1038/s41398-024-03058-9.


Changes in expression of VGF, SPECC1L, HLA-DRA and RANBP3L act with APOE E4 to alter risk for late onset Alzheimer's disease.

Branciamore S, Gogoshin G, Rodin A, Myers A Sci Rep. 2024; 14(1):14954.

PMID: 38942763 PMC: 11213882. DOI: 10.1038/s41598-024-65010-7.


The Human Brainome: changes in expression of VGF, SPECC1L, HLA-DRA and RANBP3L act with APOE E4 to alter risk for late onset Alzheimer's disease.

Branciamore S, Gogoshin G, Rodin A, Myers A Res Sq. 2024; .

PMID: 38168398 PMC: 10760217. DOI: 10.21203/rs.3.rs-3678057/v1.


Predictive network analysis identifies JMJD6 and other potential key drivers in Alzheimer's disease.

Merchant J, Zhu K, Henrion M, Zaidi S, Lau B, Moein S Commun Biol. 2023; 6(1):503.

PMID: 37188718 PMC: 10185548. DOI: 10.1038/s42003-023-04791-5.